COVID-19 vaccine development efforts from a number of Japanese pharmaceutical companies have made their way into the later stages of…...
Please subscribe to read the full story.
clinical trials
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
Mitsubishi Chemical Holdings Corp. (TYO:4188) subsidiary Life Science Institute Inc. (LSII) plans to begin clinical trials of a Muse cell-based…...
Please subscribe to read the full story.
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April
The global COVID-19 pandemic has stopped many clinical trials for new drugs in their tracks. Research from Medidata Solutions Inc.,…...
Please subscribe to read the full story.
